Cargando…
Magnesium supplementation and high volume hydration reduce the renal toxicity caused by cisplatin-based chemotherapy in patients with lung cancer: a toxicity study
BACKGROUND: Renal toxicity is a clinical problem that affects 28 − 42% of patients undergoing treatment with cisplatin. Renal toxicity can be minimized by high volume hydration with mannitol diuresis. Recent reports have shown that cisplatin induces depletion of Mg and that Mg supplementation can re...
Autores principales: | Oka, Takako, Kimura, Tatsuo, Suzumura, Tomohiro, Yoshimoto, Naoki, Nakai, Toshiyuki, Yamamoto, Norio, Matsuura, Kuniomi, Mitsuoka, Shigeki, Yoshimura, Naruo, Kudoh, Shinzoh, Hirata, Kazuto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4272804/ https://www.ncbi.nlm.nih.gov/pubmed/25472655 http://dx.doi.org/10.1186/2050-6511-15-70 |
Ejemplares similares
-
C609T Polymorphism of NADPH Quinone Oxidoreductase 1 Correlates Clinical Hematological Toxicities in Lung Cancer Patients Treated with Amrubicin
por: Nagata, Misato, et al.
Publicado: (2013) -
Plasma RANTES, IL-10, and IL-8 levels in non–small-cell lung cancer patients treated with EGFR-TKIs
por: Umekawa, Kanako, et al.
Publicado: (2013) -
Reduced CYP2D6 function is associated with gefitinib-induced rash in patients with non-small cell lung cancer
por: Suzumura, Tomohiro, et al.
Publicado: (2012) -
Interstitial Lung Disease Induced by Osimertinib for Epidermal Growth Factor Receptor (EGFR) T790M-positive Non-small Cell Lung Cancer
por: Matsumoto, Yoshiya, et al.
Publicado: (2017) -
Review of the Management of Relapsed Small-Cell Lung Cancer with Amrubicin Hydrochloride
por: Kimura, Tatsuo, et al.
Publicado: (2011)